Invesaro

Stocks Comparison

Haoxi Health Technology vs Stran &: revenue, profit, margins and growth compared

Haoxi Health Technology brought in $54.8M of revenue in fiscal 2026, Stran & $116.2M in fiscal 2025. Revenue changed by +67.1% at Haoxi Health Technology and +40.6% at Stran & on the year before, so Haoxi Health Technology grew faster. Haoxi Health Technology kept -17.4% of its revenue as net profit, Stran & -0.6%.

Side by side, latest fiscal year

HAOSWAG
Fiscal year endedFY2026 (June 30, 2026)FY2025 (December 31, 2025)
Revenue$54.8M$116.2M
Revenue growth+67.1%+40.6%
Net income-$9.5M-$747K
Net margin-17.4%-0.6%
Free cash flown/a-$5.5M
Free cash flow marginn/a-4.7%
Earnings per share (diluted)-$386.40-$0.04
Cash$10.9M$6.8M
Debt$290.7Kn/a
Price to earningsn/an/a
Market value$679.2K$25.1M
Dividend yieldn/an/a
Rank by revenue in sector#805 of 1077 · Consumer discretionary#743 of 1077 · Consumer discretionary

Over the years

Revenue
HAO FY2022: $16.2MHAO FY2024: $28.2MHAO FY2024: $48.5MHAO FY2025: $32.8MHAO FY2026: $54.8MSWAG FY2021: $37.8MSWAG FY2021: $39.7MSWAG FY2022: $57.9MSWAG FY2023: $76MSWAG FY2024: $82.7MSWAG FY2025: $116.2MFY21FY22FY23FY24FY25FY26
HAO $54.8MSWAG $116.2M
Net income
HAO FY2022: $244.6KHAO FY2024: $969.8KHAO FY2024: $1.3MHAO FY2025: $3.9MHAO FY2026: -$9.5MSWAG FY2021: $1MSWAG FY2021: $235.2KSWAG FY2022: -$3.5MSWAG FY2023: -$385KSWAG FY2024: -$4.1MSWAG FY2025: -$747KFY21FY22FY23FY24FY25FY26
HAO -$9.5MSWAG -$747K
Net margin
HAO FY2022: 1.5%HAO FY2024: 3.4%HAO FY2024: 2.7%HAO FY2025: 11.8%HAO FY2026: -17.4%SWAG FY2021: 2.7%SWAG FY2021: 0.6%SWAG FY2022: -6.0%SWAG FY2023: -0.5%SWAG FY2024: -5.0%SWAG FY2025: -0.6%FY21FY22FY23FY24FY25FY26
HAO -17.4%SWAG -0.6%
Revenue growth
HAO FY2024: +74.7%HAO FY2024: +71.9%HAO FY2025: -32.4%HAO FY2026: +67.1%SWAG FY2021: +5.2%SWAG FY2022: +45.8%SWAG FY2023: +31.3%SWAG FY2024: +8.8%SWAG FY2025: +40.6%FY21FY22FY23FY24FY25FY26
HAO +67.1%SWAG +40.6%
Free cash flow
HAO FY2022: -$684.1KHAO FY2024: -$917.6KHAO FY2024: -$802.9KSWAG FY2021: -$2.2MSWAG FY2021: -$5.7MSWAG FY2022: -$2.6MSWAG FY2023: -$3.5MSWAG FY2024: $2.2MSWAG FY2025: -$5.5MFY21FY22FY23FY24FY25
HAO -$802.9KSWAG -$5.5M

Fiscal years as each company reports them; the two may end in different months.

Questions about Haoxi Health Technology and Stran &

Which is bigger by revenue, Haoxi Health Technology or Stran &?

Stran & is bigger by revenue: $116.2M in fiscal 2025, against $54.8M for Haoxi Health Technology in fiscal 2026.

Which keeps more of its revenue as profit, Haoxi Health Technology or Stran &?

Haoxi Health Technology had a net margin of -17.4% in fiscal 2026; Stran & had -0.6% in fiscal 2025.

Which grew revenue faster, Haoxi Health Technology or Stran &?

In their latest fiscal years revenue changed by +67.1% at Haoxi Health Technology and +40.6% at Stran &.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies